Jose P. Leone, MD, director of the program for breast cancer in men at the Dana-Farber Cancer Institute and assistant professor of medicine at Harvard Medical School, shares why patients and providers need to pay more attention to how breast cancer impacts male patients.
More patients and providers need to be aware that breast cancer can happen in men in order to improve treatment and survival rates in this population, according to Jose P. Leone, MD, director of the program for breast cancer in men at the Dana-Farber Cancer Institute and assistant professor of medicine at Harvard Medical School.
Transcript
How has the diagnosis and treatment of men with breast cancer evolved over time, and what more needs to be done to ensure adequate treatment for this population?
Leone: So, breast cancer treatment in men has historically mirrored the treatment for women. And many of those things are actually still being done today. So, for example, the use of tamoxifen as a standard endocrine therapy option in men remains the current standard today. The use of mastectomy initially, and then, the adoption of other possible surgical options, such as lumpectomy in men, has been something that has changed over time also. We look forward to having more data in some of the questions that we have in clinics to move the field forward in the treatment of breast cancer in men and to get data specific for men as compared with women.
What are some of the challenges that are unique to treating men with breast cancer?
Leone: One of the biggest challenges is the lack of data specific for men. Sometimes there are no studies done to answer a particular question. Sometimes the studies are of lower quality than the size that we're used to seeing in women. And that, to me, is one of the biggest challenges in in managing this type of breast cancer.
What do you wish that more oncologists and health care professionals understood about breast cancer in male patients?
Leone: One of the main things for me, personally, I think, is awareness and to be aware that breast cancer can happen in men because early diagnosis of men who present with signs and symptoms of breast cancer is very important given the lack of screening mammograms in this population. So, I would like people to be aware that this can happen and not delay to the workups, which sometimes happens.
Could On-Body Delivery of Isatuximab Bring More Competition to Anti-CD38 Myeloma Treatment?
June 6th 2025Results for IRAKLIA show noninferiority for Sanofi's on-body delivery system for isatuximab, compared with IV administration. Patients overwhelmingly preferred the hands-free delivery option.
Read More
Laundromats as a New Frontier in Community Health, Medicaid Outreach
May 29th 2025Lindsey Leininger, PhD, and Allister Chang, MPA, highlight the potential of laundromats as accessible, community-based settings to support Medicaid outreach, foster trust, and connect families with essential health and social services.
Listen
Zanubrutinib Shows Durable Benefit for High-Risk CLL/SLL at 5 Years in SEQUOIA Trial
June 6th 2025Zanubrutinib showed long-term efficacy in patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) and deletion of the 17p chromosome, with progression-free survival similar to patients without high-risk disease characteristics.
Read More
Real-World Data Support Luspatercept vs ESAs for Anemia in Lower-Risk MDS
June 5th 2025Patients with myelodysplastic syndrome (MDS) who received luspatercept showed greater hemoglobin gains and transfusion independence compared with erythropoiesis-stimulating agents (ESAs) in a real-world analysis.
Read More
At EHA 2025, Hematology Discussions Will Stretch Across Lifespans and Locations
June 5th 2025The 2025 European Hematology Association (EHA) Congress, convening virtually and in Milan, Italy, from June 12 to June 15, 2025, will feature a revamped program structure for the meeting’s 30th anniversary while maintaining ample opportunities to network, debate, and absorb practice-changing findings in hematology and oncology.
Read More